EICHORPublic-registry site landscape for NCT05822245, “A Study of PER-001 in Participants With Open-Angle Glaucoma”, a Open-angle Glaucoma study sponsored by Perfuse Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05822245 (registry record) |
| Study title | A Study of PER-001 in Participants With Open-Angle Glaucoma |
| Official title | A Phase 1/2a Study to Evaluate Safety, Tolerability, and Pharmacodynamic Effect After Single Administration of PER-001 Intravitreal Implant in Participants With Open-Angle Glaucoma |
| Sponsor | Perfuse Therapeutics, Inc. |
| Condition(s) | Open-angle Glaucoma |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 1 |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT05822245.
Eichor generates a preliminary site-risk snapshot for NCT05822245 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Open-angle Glaucoma trials
More from Perfuse Therapeutics, Inc.
← Eichor home · All tracked trials · Open-angle Glaucoma studies · Weekly briefs
